South Korea licenses 11 functional cosmetic claim categories, like wrinkle care or UV protection. In contrast, the US FDA pre-approves no cosmetics. Under US law, functional claims alter a product's intended use—reclassifying a cosmetic as an unapproved drug. While MoCRA increases US facility listings, domestic Korean claims on exported goods still cause import detentions and refusals.
